Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Today’s podcast brings together two leading experts in mental health and pituitary disease for an in-depth round-table discussion of mental and emotional issues that affect people daily.
Today’s podcast covers my conversation with Jill Sisco, president of the Acromegaly Community, about the recent meetings with the Food and Drug Administration (FDA), the US governmental entity responsible for approving new medications.
On today’s podcast and Cushing’s awareness day and month, we bring you a few excerpts from our soon-to-be-released new book on Cushing’s. The book’s author and Pituitary World News cofounder, Dr. Lewis Blevins, reads from a few selected chapters to give insight into the book’s content.
Today’s podcast is about our super athlete friend Risa August and her new book about her acromegaly experience, her life, and her 1,800 mile ride from Canada to Mexico.
Spain and Spanish-speaking countries have been our focus as we seek to develop more content in Spanish for our edition of Pituitary Word News in Español. Today’s podcasts covers part of the conference and shares my conversations with three world-renowned Spanish endocrinologists.
In today’s podcast, we talk with Giacomo Chiesi, Head of Global Rare Diseases at the Chiesi Group, where he leads a team in developing and marketing treatments for rare and ultra-rare diseases.
In today’s podcast, Veronica, an MBA graduate of Notre Dame University and law school student, tells us about her experience with a prolactinoma. What is interesting about this story is that in pituitary medicine, where delays in diagnosis and general unawareness are all too often the order of the day, this is a perfect example of how awareness and smart thinking make things work as they are supposed to.
Podcast and Video: In today’s podcast and accompanying video, Dr. Blevins discusses and illustrates the case of a patient with a double pituitary adenoma.
Today, Dr. Scott Struthers talks to PWN about paltusotine, their new once-a-day oral drug candidate, which recently completed phase 3 of the clinical trial.